BRIEF published on 12/04/2025 at 20:20, 9 months 9 days ago SAFE : Résultats annuels 2024 et rapport financier publié Chiffre D'affaires Trésorerie Reorganisation Résultats 2024 SAFE
BRIEF published on 12/04/2025 at 20:20, 9 months 9 days ago SAFE: 2024 Annual Results and Financial Report Published Revenue Treasury Reorganization 2024 Results SAFE
BRIEF published on 12/04/2025 at 20:20, 9 months 9 days ago Galimedix Therapeutics Reveals Promising Phase 1 Results for GAL-101 Phase 1 Results GAL-101 Alzheimer’s Treatment Blood-brain Barrier Phase 2 Planning
BRIEF published on 12/04/2025 at 20:20, 9 months 9 days ago Galimedix Therapeutics dévoile des résultats prometteurs de phase 1 pour le GAL-101 Résultats De La Phase 1 GAL-101 Traitement De La Maladie D'Alzheimer Barrière Hémato-encéphalique Planification De La Phase 2
BRIEF published on 12/04/2025 at 19:35, 9 months 9 days ago Emerging Risks in the Gold Market: The Case for New Verification Technologies Financial Stability Gold Market SMX Innovations Verification Technology Counterfeit Risk
BRIEF published on 12/04/2025 at 19:35, 9 months 9 days ago Risques émergents sur le marché de l'or : plaidoyer pour de nouvelles technologies de vérification Stabilité Financière Marché De L'or Innovations SMX Technologie De Vérification Risque De Contrefaçon
BRIEF published on 12/04/2025 at 19:18, 9 months 9 days ago État des droits de vote et actions de MERCIALYS Droits De Vote Capital Social Paris Assemblée Générale MERCIALYS
BRIEF published on 12/04/2025 at 19:18, 9 months 9 days ago Status of voting rights and shares of MERCIALYS Share Capital Voting Rights Paris General Assembly MERCIALYS
BRIEF published on 12/04/2025 at 19:15, 9 months 9 days ago SCHOTT Pharma Reports Preliminary 2025 Financial Results EBITDA Margin Mid-term Guidance Drug Delivery Systems Preliminary Results 2025 Financial Forecast 2026
BRIEF published on 12/04/2025 at 19:15, 9 months 9 days ago SCHOTT Pharma publie ses résultats financiers préliminaires pour 2025 Marge D'EBITDA Systèmes D'administration De Médicaments Orientations À Mi-parcours Résultats Préliminaires 2025 Prévisions Financières 2026
Published on 09/12/2026 at 02:35, 1 day 19 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 23 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 2 days ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 5 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/13/2026 at 16:45, 5 hours 29 minutes ago Journées européennes du patrimoine : un succès populaire pour l'ouverture exceptionnelle du Siège de la Vaudoise
Published on 09/12/2026 at 17:50, 1 day 4 hours ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 14 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 23 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 2 days ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 07:00, 2 days 15 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 15 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 3 days 2 hours ago Availability of the 2026 Interim Financial Report
